News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
FDA approved Bristol Myers Squibb’s Opdivo + Yervoy for first-line treatment of MSI-H/dMMR metastatic colorectal cancer
Bristol Myers Squibb/bms.com
May 10, 2025, 17:01

FDA approved Bristol Myers Squibb’s Opdivo + Yervoy for first-line treatment of MSI-H/dMMR metastatic colorectal cancer

Fight Colorectal Cancer shared a post on LinkedIn:

“Congratulations to Bristol Myers Squibb on the FDA approval of Opdivo (nivolumab) + Yervoy (ipilimumab) for first-line treatment of patients with MSI-H/dMMR metastatic Colorectal Cancer!
This milestone marks a major advancement in immunotherapy for colorectal cancer, offering a powerful option for patients with microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) tumors-an important subset of the CRC population.
At Fight CRC, we believe every colorectal cancer patient deserves access to comprehensive biomarker testing from the moment of diagnosis. Approvals like this one reinforce the value of identifying MSI-H/dMMR status early so patients can benefit from treatments that are matched to their tumor biology.”

Read more about Opdivo + Yervoy here.

Learn more about FDA and colorectal cancer on OncoDaily.

Bristol Myers Squibb cancer colorectal cancer FDA Fight Colorectal Cancer ipilimumab nivolumab OncoDaily Oncology Opdivo Yervoy
Special Coverage
Drugs
May 10, 2025, 17:01
FDA approved Bristol Myers Squibb’s Opdivo + Yervoy for first-line treatment of MSI-H/dMMR metastatic colorectal cancer
Blog
May 10, 2025, 16:48
Sylvester Nurses Recount Their Career Paths at the Same Cancer Center - Sylvester Comprehensive Cancer Center
Societies
May 10, 2025, 16:46
European Cancer Organisation announced open submissions for European Cancer Summit 2025 abstracts
Blog
May 10, 2025, 16:29
Galip Can Uyar: Treatment in Older Adults is no Longer Guided by Age Alone, But by Frailty and Functional Status
Career
May 10, 2025, 16:24
Estela Rodriguez congratulates Chinmay Jani on being named GRACE 2025-2026 Education Ambassador
Blog
May 10, 2025, 16:16
Sachin Jain: Rethinking the MD/MBA Pathway
Insight
May 10, 2025, 16:12
Patrick Hwu highlights 2025 study by Jonathan Zager on Melphalan hepatic perfusion for metastatic uveal melanoma
Celebrities
May 10, 2025, 16:06
In Memory of Bob Marley: His Battle with Melanoma and the Importance of Early Detection
Blog
May 10, 2025, 16:04
Ruben Mesa Shares Personal Skin Cancer Experience to Raise Awareness
Career
May 10, 2025, 15:50
Bill Gates: The Last Chapter of My Career
Opinion
May 10, 2025, 15:49
Tanja Obradovic Highlights FDA's input and critical role in advancing cell therapy field
Blog
May 10, 2025, 15:35
Gregg Margolis: Three Things to Read About Health Policy This Week